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This review describes four cognitive approaches for the treatment of schizophrenia: cognitive-behavioral therapy for 
psychosis (CBTp), metacognitive therapy, metacognitive training, and metacognitive reflection insight therapy (MERIT). 
A central reference point of our review is a seminal paper by James Flavell, who introduced the term metacognition 
(“cognition about cognition”). In a way, every psychotherapeutic approach adopts a metacognitive perspective when 
therapists reflect with clients about their thoughts. Yet, the four approaches map onto different components of metacognition. 
CBTp conveys some “metacognitive knowledge” (eg, thoughts are not facts) but is mainly concerned with individual 
beliefs. Metacognitive therapy focuses on unhelpful metacognitive beliefs about thinking styles (eg, thought suppression). 
Metacognitive training brings distorted cognitive biases to the awareness of patients; a central goal is the reduction of 
overconfidence. MERIT focuses on larger senses of identity and highlights metacognitive knowledge about oneself and 
other persons. For CBTp and metacognitive training, meta-analytic evidence supports their efficacy; single studies speak 
for the effectiveness of MERIT and metacognitive therapy.
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Introduction
Most contemporary psychotherapies have the term “cogni-
tive” in their name, either alone or as a prefix or suffix, as 
in cognitive-behavioral therapy (CBT) and metacognitive 
therapy. This complicates differentiation for patients who 
seek special treatments, but at times also confuses experts. 
Seemingly subtle terminological differences often hide 
considerable diversity. For example, cognitive training is very 
different from cognitive therapy; the former means neurocog-
nitive rehabilitation, the latter is a core component of CBT. 
The situation has become even more complicated with the 
emergence of a so-called third wave of CBT including meta-
cognitive interventions, which are at the center of this review. 
This review will discuss differences and similarities among 
four prominent cognitive treatment approaches in schizo-
phrenia: CBT for psychosis (CBTp),1 metacognitive therapy,2 
metacognitive training3 and metacognitive reflection insight 
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teristics of these therapies as well as the latest evidence for 
their efficacy. A central reference point of our review is the 
seminal paper by James H. Flavell from 19795 who intro-
duced the term metacognition (“cognition about cognition” or 
“thinking about thinking”). In a way, most psychotherapeutic 
interventions adopt a metacogni-
tive approach as therapists reflect 
with their patient about their cogni-
tions and associated feelings (eg, 
memories relating to prior negative 
experiences, coping strategies) and 
try to alter unhelpful thoughts and 
beliefs. As two of us have specu-
lated before,6 if the word meta-
cognitive had been around earlier, 
CBT may have already been 
termed metacognitive-behavioral therapy. Metacognition is 
a multifaceted concept, and the seeming similarity in labels 
should not obscure the fact that the four treatments map 
onto different aspects of the construct, or at least emphasize 
different aspects of metacognition.
Metacognition 
As mentioned above, each psychotherapy involves thinking/
reflecting about thinking/thoughts. Metacognition is a 
superordinate concept that was put forward in the 1970s 
but actually looks back at a longer history. Prior terms were 
“cognizing about cognition” (Plato) or “knowledge about 
knowledge.”7 Flavell5 was the first to define its essential 
components, which were later complemented by other theo-
rists, for example Asher Koriat.8,9 Flavell distinguished four 
aspects of metacognition: (i) metacognitive knowledge; (ii) 
metacognitive experiences; (iii) metacognitive goals (or 
tasks); and (iv) metacognitive actions (or strategies). In this 
review, we will mainly deal with the two former. Flavell 
defines metacognitive knowledge as stored world knowl-
edge that has to do with people as cognitive beings and with 
their diverse cognitive tasks, goals, actions, and experiences.5 
Metacognitive knowledge can relate to persons (eg, “the 
British think they are funnier than other nations”), oneself 
(eg, “I am good at statistics”) as well as others, but can also 
be beliefs about “universal properties of cognition” (p 907). 
An example of the latter would be “evil thoughts can lead to 
evil actions.” Metacognitive experiences are conscious reflec-
tions about cognitive processes (eg, worrying that others have 
found you boring at last night's party). 
Cognitive behavior therapy for psychosis 
Cognitive behavior therapy for psychosis (CBTp)1,10-12 is the 
approach with the longest history and the largest evidence 
base.13 CBTp amalgamates elements from behavioral 
therapy and the so-called second or 
“cognitive wave,” and increasingly 
incorporates elements originated 
from the “third wave” of CBT.14 
Manuals differ as to the weight 
and execution of these elements. 
Yet, there is a consensus about 
core elements that are defined by 
the National Institute for Health 
and Care Excellence (NICE) 
guidelines15: (i) establishing links 
between patients’ thoughts, feelings, or actions and their 
current or past symptoms and their functioning; (ii) re-eval-
uation of patients’ perceptions, beliefs, or reasoning related to 
the symptom; (iii) monitoring of thoughts, feelings, or behav-
iors related to symptoms; and (iv) promoting alternative ways 
of coping with symptoms, reducing distress, and improving 
functioning. 
The first CBTp manuals aimed at changing psychotic symp-
toms directly by using cognitive interventions such as iden-
tification of automatic thoughts (“I might be followed by 
the FBI”) and their re-evaluation. In addition, behavioral 
interventions were implemented, particularly developing 
new adaptive coping strategies for distressing symptoms 
and positive activities. Exposure, a central element of CBT 
in general, is usually performed in a more gentle way in 
psychosis as “reality testing”: patients are motivated to test 
unrealistic automatic thoughts that evoke fear (“other people 
will hear my thoughts”). Further, graded and prolonged expo-
sure were introduced as a regular part of interventions for 
patients with psychosis who displayed additional comorbid 
anxiety or posttraumatic stress disorders, and proved effec-
tive in terms of reducing psychotic and post-traumatic stress 
disorder symptoms.16 
Whereas traditional CBTp interventions focus on symptom 
change, third-wave CBTp interventions aim to promote the 
acceptance of symptoms as in Acceptance and Commitment 
therapy,17 and to address negative thoughts and emotions by 
using strategies such as mindfulness,18 exposure to negative 
emotions, and imagination techniques including compas-
Cognitive and metacognitive  
approaches to the treatment  
of schizophrenia have  
a growing evidence base  
demonstrating their efficacy
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sionate mind training.19 In addition, these third-wave inter-
ventions focus on achieving life goals and recovery. 
CBT also adopts a metacognitive perspective in the sense that 
therapists and patients discuss and challenge negative thoughts 
and maladaptive beliefs. CBT conveys metacognitive knowl-
edge, particularly that thoughts are thoughts and should not 
be regarded as facts. Moreover, CBT shows that there is no 
universal way to respond to a certain situation (eg, failing an 
exam) emotionally (eg, anger, frustration); situations/events 
can be appraised and coped with in different ways. 
CBTp is strongly recommended in all phases of psychotic 
disorders by many national guidelines, for example by 
the British NICE guidelines,15 and the German Society of 
Psychologists guidelines (DGPs)20 as well as the German 
Society of Psychiatrists (DGPPN) guidelines.21 
Most meta-analyses assert the efficacy of CBTp compared 
with treatment as usual (TAU) and identified a small to 
medium effect in favor of CBTp with regard to positive 
symptoms like hallucinations,22 general symptoms, and 
social functioning.23,24 Further, there is evidence that CBTp 
is efficient in patients who choose not to take antipsychotic 
medication.25 Its effects on prodromal/at-risk patients have 
become somewhat more elusive over the years.26,27 
Usually, CBTp encompasses four to 30 sessions, and the 
effects are best if at least 20 sessions are administered.28 
One recent meta-analysis was published by one of us29 and 
showed that CBTp exerts a small effect on delusions. This 
meta-analysis was criticized by Laws,30 who reanalyzed the 
data and argues that the effect of CBTp on change in delu-
sions is not stable over a follow-up period of 18 months. 
Indeed, it seems important to search for ways to stabilize 
effects over time. 
Daniel Freeman and Philippa Garety argue that we should 
concentrate less on changing delusions directly, but should 
instead target factors that might cause delusions such as 
worrying and reasoning biases31-33 the latter is a core aim of 
metacognitive training, which will be discussed later. 
Metacognitive therapy
Metacognitive therapy has been developed by Adrian Wells 
and colleagues and has mainly been evaluated in anxiety and 
depression.34-36 This approach assumes that mental disorders 
are linked to the activation of a “toxic style” of thinking called 
the cognitive attentional syndrome (CAS), which locks indi-
viduals in emotional states that would otherwise be temporary 
(sadness, anxiety, anger, etc). The main features of this cogni-
tive style are: (i) worry and rumination; (ii) threat monitoring; 
and (iii) dysfunctional coping behaviors. The model assumes 
that the CAS is maintained by dysfunctional metacognitive 
beliefs such as “rumination helps me find answers to my 
problems.” 
The model is transdiagnostic in nature; the CAS in psychosis 
is similar to that in other mental disorders. Paranoid thinking 
is likened to the process of worrying: a series of “what if” 
questions (“what if the FBI is behind me?”). These ques-
tions are perhaps more bizarre than for example in anxiety 
disorder (“what if I had cancer?”) but are essentially similar. 
The response to hallucinatory experiences is comparable to 
the process of rumination in depression: these patients rumi-
nate about why they feel depressed, patients with psychosis 
ruminate about why they are hearing these voices and who 
is orchestrating the phenomena. 
These examples highlight the transdiagnostic nature of meta-
cognitive therapy. Formulating the CAS can help the patient 
understand that dysfunctional cognitive strategies are the 
maintaining factor for paranoid thinking and hallucinatory 
experiences. As mentioned, the CAS itself is maintained by 
dysfunctional metacognitions. These can be divided into posi-
tive and negative metacognitions. Positive metacognitions 
concern the perceived usefulness of worry and rumination 
(“if I worry about the FBI following me, I can prevent them 
from catching me”). Negative metacognitions are focusing 
on perceived uncontrollability (“it bothers me that I cannot 
stop thinking about why my voices occur”) or the perceived 
danger of cognitions (“if I keep on worrying about this I will 
totally lose control”). 
The goal of metacognitive therapy is to increase cognitive 
flexibility, modify metacognitive beliefs, and decrease the 
CAS (eg, reduction of dysfunctional coping strategies). Strat-
egies can be divided into experiential strategies (eg, practising 
detached mindfulness, ie, letting go of an experience rather 
than trying to change or control it) and knowledge-based 
strategies (eg, challenging metacognitive beliefs). These strat-
egies go hand in hand as shown in the following example. A 
woman was suffering from command hallucinations that told 
312 • DIALOGUES IN CLINICAL NEUROSCIENCE • Vol 21 • No. 3 • 2019
Original article
Psychosis: metacognitive and cognitive-behavioral interventions - Moritz et al
her to harm members of her family. Her trigger thought was 
“what if the voices can make me kill my children?” (Note 
how the focus of the conceptualization is not the content of 
the voices but how the patient reacts to them). She worried 
continuously about these voices. Her worries were maintained 
by the metacognitive belief “my loved ones will only be safe 
if I worry.” The patient avoided reading bedtime stories to 
her children because she believed that she would kill her son 
if she did so (dysfunctional coping behavior). In sessions, 
she trained in detached mindfulness with her therapist, who 
showed her to react more flexibly to the auditory hallucina-
tions by switching between engaging and disengaging from 
the experience. This experience somewhat reduced her meta-
cognitive beliefs and she started reading bedtime stories to 
her son again. 
To date, one multiple baseline study (N = 3)37 and one case 
series (N = 10) have demonstrated the effectiveness of up to 
twelve sessions of metacognitive therapy in medication-re-
sistant patients with schizophrenia spectrum disorder with a 
large pre- to posteffect size.38 For other mental disorders the 
efficacy of metacognitive therapy is well-proven.34,39 
Metacognitive training for psychosis 
In the last years, metacognitive training has been adapted 
for a number of disorders including bipolar disorder, obses-
sive-compulsive disorder, and depression as well as border-
line personality disorder. The treatment, however, was first 
developed for psychosis and intended as a translational 
approach aimed at “straightening” cognitive distortions. 
Metacognitive training was largely inspired by a 1999 review 
on cognitive factors in paranoia40 which highlighted the role 
of data gathering/jumping to conclusions (JTC), theory of 
mind/social cognition and attributional style. The authors 
also translated their own research pertaining to a bias against 
disconfirmatory evidence41 and overconfidence42 into some 
modules. An overarching theme of metacognitive training is 
to convince patients to gather more information, that is, to 
diminish a JTC bias, and to reduce overconfidence in errors, 
especially for momentous decisions.3 Importantly, awareness 
of these biases is often poor in patients.43,44 The metacognitive 
aspect that sets apart metacognitive training from the other 
approaches described in this review is the attenuation of over-
confidence (ie, “sowing the seeds of doubt”) which according 
to the metacognitive model of Koriat9 and others represents a 
central element of metacognition (see also ref 45). 
Yet, like CBT (eg, a thought is a thought and not a fact) 
and metacognitive therapy (eg, rumination does not help 
to solve problems) metacognitive training also conveys 
some metacognitive knowledge by raising metacognitive 
awareness for cognitive biases. The training is aimed to 
correct errors in a gentle, non-confrontational manner that 
gives rise to memorable metacognitive experiences (“aha 
moments”) that Flavell already introduced. 
Over the years, metacognitive training has been translated 
into various languages (currently 37) and complemented by 
other treatment techniques. While the authors of metacog-
nitive training dispute the general claim by Capobianco and 
Wells46 that the “intervention is clearly a cognitive behavioral 
approach that deals with the content of negative thoughts” 
(p 161), it is true that its most recent modules on depression 
and self-esteem have a CBTp signature and metacognitive 
training can thus be considered a variant of CBTp. These 
modules were introduced because patients with schizo-
phrenia regard work on emotional problems as a top priority 
that is weighted as more important than work on positive 
symptoms.47-49 Some modules contain exercises that are 
used in metacognitive therapy as well (eg, demonstrating 
the dysfunctionality of thought suppression with the “pink 
elephant exercise,” which however is older than metacog-
nitive therapy and often carried out in CBT). Metacognitive 
training is perhaps the most heterogeneous of all approaches 
and the authors have hence begun to explore the specific 
contribution of individual modules.50 
Metacognitive training is now recommended as a treatment 
for psychosis by the Australian Psychiatric Association51 
as well as the German Psychiatric Association (DGPPN)21 
and the German Psychological Association (DGPs).20 
Several meta-analyses on its effectiveness have been 
published over the years. The two most recent ones39,52 
show that the training exerts a small to medium effect on 
symptoms when compared to other interventions (pooled 
effect). Adherence is usually good, and patients prefer the 
training over other forms of treatment at a large effect 
size.53 The study by Liu et al52 also suggest that the effects 
are maintained over a follow-up period. Several changes 
have been introduced over the years to enhance effects, for 
example, the development of parallel versions. Patients are 
now advised to participate in at least two cycles. Further, 
the individualized format (MCT+) allows greater consider-
ation of personal problems. To maintain treatment success 
DIALOGUES IN CLINICAL NEUROSCIENCE • Vol 21 • No. 3 • 2019 • 313
Original article
Psychosis: metacognitive and cognitive-behavioral interventions - Moritz et al
in the long run an app has been developed which can be 
downloaded free of charge via www.uke.de/mct_app in 
German and English (iOS and Android). The app can be 
used to assist metacognitive training for mental disorders 
beyond psychosis and a beta version has recently been 
successfully tested in depressed patients.54
Metacognitive insight and reflection therapy
The term schizophrenia originally described psychotic 
disorders as conditions in which goal-directed behavior 
collapses because of the fragmentation or loss of coherence 
of three principle areas of psychological functions: cognition, 
emotion, and volition.55 MERIT56 is a treatment designed to 
address these experiences of fragmentation. MERIT relies on 
the integrated model of metacognition57 which uses the term 
metacognition to describe both the top-down and bottom-up 
processes which allow for the elements of cognitive, 
emotional, social and embodied experience to be synthesized 
into a larger sense of self within the flow of life. When meta-
cognitive processes are disrupted, persons become unable to 
integrate information in order to form a larger sense of the 
self and others, leading to the kinds of fragmented experi-
ence originally thought to be the core of psychosis. Evidence 
supporting these views includes cross-cultural studies docu-
menting relatively pronounced greater metacognitive deficits 
in persons diagnosed with psychosis and association between 
metacognitive deficits with concurrent and future levels of 
psychosocial impairment.58-60
MERIT seeks to treat fragmentation by enhancing metacogni-
tive capacity or the ability to integrate information about the 
self and others. The development of metacognitive capacity 
is presumed to promote recovery when enhanced metacog-
nitive capacities allow persons to achieve greater levels of 
intimacy with others, to form their own sense of the psycho-
social challenges they face, and ultimately direct their own 
recovery as active agents in the world.61 MERIT is an integra-
tive individual psychotherapy that can flexibly meet the needs 
of patients with different goals, challenges, and abilities with 
the optimal length of treatment varying given the severity 
of metacognitive deficits. MERIT assumes that the use of a 
single approach is unlikely to be able to be fully responsive 
given the complexity of the experience of psychosis.
To enhance metacognition, MERIT relies on eight processes, 
referred to as elements, which therapists should engage in 
within each session. These elements are observable interre-
lated therapist behaviors which together are intended to help 
patients become better able to observe and integrate their 
experience of themselves and others in the world. These 
processes are consistent with the common factors of psycho-
therapy and can be deployed by therapists from different 
theoretical orientations. 
The eight elements of MERIT are divided into three groups. 
The first four, the content elements, require explicit attention 
to; (i) the development of a joint understanding of patients’ 
agendas, (ii) ongoing therapeutic dialogue; (iii) patients’ 
narratives; and (iv) psychosocial challenges. The next two, 
the process elements, require: (v) reflection on the interper-
sonal processes within session; and (vi) consideration of 
the session’s effects on patients’ cognitive and emotional 
and embodied experience within the session. The last two 
elements, the superordinate elements, necessitate therapist 
interventions that match patients’ metacognitive capacity for: 
(vii) reflection about the self and others; and (viii) metacog-
nitive mastery or the ability to use metacognitive knowledge 
to respond effectively to psychosocial challenges.56 MERIT, 
consistent with CBTp, emphasizes the development of the 
therapeutic alliance and reflection upon patients’ experience 
of their feelings and thoughts. It moves beyond these common 
aspects in its holistic consideration of how embodied and 
prereflective experience are integrated intersubjectively 
within session, alongside more effortful forms of cognition, 
to allow persons to make their own unique sense of their 
challenges and to respond as agents
Evidence supporting MERIT includes two randomized, 
controlled trials, lasting 8 and 6 months respectively, which 
reported that MERIT was accepted by over two-thirds of 
patients and led to meaningful gains.62,63 Similar findings 
were reported in a 12-week open trial of MERIT64 and a 1- 
to 2-year course of metacognitively focused psychotherapy 
which conformed to MERIT.65 A long term follow-up 
conducted among participants of the latter study found gains 
in metacognition and psychosocial functioning persisted over 
3 years.66 Qualitative studies have found MERIT results in 
subjective changes in sense of self-related to enhanced agency 
and self-management.67,68 Detailed case studies have illus-
trated how MERIT can be applied to patients with complex 
clinical presentations including patients with complaints 
commonly thought to be intractable including negative symp-
toms, disorganization, and lack of insight.69 
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Shared and unspecific factors deserve greater 
consideration
Developers of psychotherapeutic treatments often highlight 
(allegedly) unique features of a treatment (eg, reduction of 
confidence in metacognitive training, mindfulness in mind-
fulness-based treatments) and at times evoke the impression 
as if these features were the main mechanisms of change. 
Yet, different psychotherapeutic “schools” share numerous 
common factors. If psychotherapy was a pharmacological 
agent it would be best characterized as a “dirty drug,” that 
is, a substance with very different modes of action. At the 
same time, treatments with the same label may be carried out 
very differently. A CBTp treatment according to the model 
of Freeman and Garety,32,33 which, as shown, highlights 
reasoning and worrying will be different than a treatment 
according to the first CBTp textbooks (see above). Different 
treatment approaches allow therapists different degrees of 
freedom and standardization is thus often poor. 
Some of the features shared by psychotherapies go unmen-
tioned as they seem trivial. However, since they may 
contribute to the overall efficacy of a treatment they deserve 
greater consideration.70 Implicit and sometimes explicit to all 
psychotherapeutic treatments for psychosis is the suggestion 
that a severe disorder like schizophrenia can be psycholog-
ically understood and treated thus instill patients with hope, 
especially if therapists point out evidence for the efficacy 
of a specific treatment. The extent to which efficacy/hope 
is conveyed to participants versus potential adverse effects 
are disclosed is seldom reported in trials, although we know 
that, for example, expectancy enhances efficacy.71 Some 
treatments, at least CBTp, metacognitive training, and indi-
vidualized metacognitive training (MCT+) but not group 
metacognitive training, provide the patient with an indi-
vidual illness model, sometimes a difficult task in light of 
patients’ delusional explanations for their problems and their 
often poor level of insight. The dosage of therapy in terms of 
format (group, individual, unguided), number of sessions, and 
also competence of the facilitator represent other important 
moderators that hinder direct comparison among treatments, 
even those with the same label. While metacognitive therapy, 
CBTp, and MERIT should be conducted by psychotherapists 
who have followed a special curriculum for the technique, 
this is not a precondition for metacognitive training/MCT+. 
Metacognitive therapy and metacognitive training are usually 
brief (8 to 10 sessions) while CBTp is recommended to be 
conducted for at least 16 to 25 sessions72 in most intervention 
studies (however, the CBTp studies by Freeman and Garety 
cited above often use 4 to 6 sessions), which may impact 
outcome but also applicability in routine care with often short 
hospital stays and staff that is not specialized for a certain 
treatment approach. 
It is beyond the scope of this review, but it may be useful 
for future work, to explicitly describe therapeutic techniques 
in a manner that is analogous to chemical formulae in order 
to allow to the detection of whether a therapeutic feature is 
present or not. This may also help to distinguish among trials 
that evaluate the same intervention but with variations (eg, 
length, weighting of elements). 
The overlap in terms of additional procedures (eg, psycho-
education, illness model) may also be a reason why there is 
some obvious reluctance to conduct trials that compare the 
treatments highlighted in this review. Non-inferiority is by no 
means unlikely – however, see ref 73 – even more so as many 
patients receive concomitant treatment either applied face-to-
face or via self-help material that is increasingly available for 
schizophrenia too. 
Conclusion 
As shown, the psychotherapeutic methods covered in 
this review all have a metacognitive feature. The unique 
features are perhaps best summarized as follows: Metacog-
nitive therapy takes a transdiagnostic approach; treatment 
for patients with schizophrenia is essentially not much 
different to treatment for patients with other disorders. The 
treatment focuses on false or unhelpful (positive or nega-
tive) beliefs people hold about rumination and worrying 
processes (metacognitive knowledge). It is perhaps the 
most explicit on what to do during treatment and what not 
to do (usually no work on personal idiosyncratic beliefs 
or thoughts is encouraged). Metacognitive training aims 
at bringing distorted mental processes (cognitive biases) 
to the awareness of patients and triggering change through 
new metacognitive (“aha”) experiences. Progress is made 
through an attenuation of overconfidence.74 CBTp also has 
some metacognitive knowledge "mantras” (thoughts are 
thoughts and not facts) but is mainly concerned with idio-
syncratic (schematic) dysfunctional beliefs that metacog-
nitive therapy for example avoids to address by all means. 
As shown, it is the treatment with the largest number of 
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studies to date.MERIT focuses on larger senses of iden-
tity and especially metacognitive knowledge about oneself 
and other persons. Like CBTp, it is more a toolbox than a 
standardized treatment. The treatment depends largely on 
patients’ preferences and goals, thus ultimately limiting 
standardization. Two CBTp and MERIT therapists may 
work differently with the same patient.
All treatments have a growing basis of evidence demon- 
strating efficacy, especially CBTp and metacognitive training, 
but studies show that metacognitive therapy and MERIT 
also seem to improve symptoms of psychosis. Despite many 
unique features that set these approaches apart, their common 
factors need more extensive consideration in the future. In 
addition, it is interesting to assess which therapeutic elements 
drive change. Subsequent research needs to address which 
elements are perhaps disposable, whether a certain treatment 
sequence is especially helpful, and which modules/exercises 
are perhaps redundant. n
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